FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed is medication, which has diuretic activity. Medication represents 4-chloro-2-((5-iodinefurane)methylamino)-5-sulphamylbenzoic acid (formula 1), has diuretic activity of saluretic group and can be applied for treatment of stagnant phenomena in greater and lesser blood circulation, conditioned by impaired cardiac function.
EFFECT: substance initially increases release of sodium ions from organism and secondly enhances water excretion, thus favouring edema reduction; compound is more active than furosemide by 80%.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICATION, POSSESSING DIURETIC ACTION | 2012 |
|
RU2517091C2 |
DIURETIC AGENT | 2012 |
|
RU2487714C1 |
DIURETIC AGENT | 2012 |
|
RU2500407C2 |
DIURETIC AGENT | 2012 |
|
RU2484826C1 |
AGENT HAVING DIURETIC AND ANTI-INFLAMMATORY ACTION | 2013 |
|
RU2522925C1 |
HERBAL REMEDY WITH DIURETIC AND NATRIURETIC ACTIVITY FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE URINARY SYSTEM | 2022 |
|
RU2791782C1 |
COMPOSITION WITH DESAMINO-ARGININE VASOTOCIN FOR PARENTERAL INTRODUCTION AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2634272C1 |
DIURETIC | 2009 |
|
RU2408367C1 |
USE OF HYPEROZIDE AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802832C1 |
USE OF QUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802833C1 |
Authors
Dates
2011-04-20—Published
2009-10-05—Filed